Market
What percentage of patients will achieve 75-80% tumor reduction by end of 2025?
2
Russia•Ministry of Health•Gamaleya National Research Center•Andrey Kaprin•Radiology Medical Research Center•Russian Ministry of Health•Russian
Resolution / Starting Odds
Less than 50% • 25%
50% to 74% • 25%
75% to 80% • 25%
More than 80% • 25%
Clinical trial results or official health reports
Story
Russia to Launch Free mRNA Cancer Vaccine in 2025, Aims for 75-80% Tumor Reduction
Dec 17, 2024, 09:02 PM
Russia's Ministry of Health has announced the development of a personalized cancer vaccine using mRNA technology, set to be distributed to patients for free starting in early 2025. The vaccine, developed by the Gamaleya National Research Center, is designed to treat cancer patients rather than prevent cancer in the general public. It aims to suppress tumor growth and prevent the spread of cancer, with early trials showing the ability to reduce tumor size by 75-80% and slow tumor progression. Andrey Kaprin, the General Director of the Radiology Medical Research Center of the Russian Ministry of Health, stated that the vaccine will be personalized for each patient's specific cancer type. The Russian government has given the green light for mass production of the vaccine, which is expected to cost the state 300,000 rubles per dose.
View original story
Similar markets
25% to 50% of major hospitals • 25%
More than 50% of major hospitals • 25%
Not adopted • 25%
Less than 25% of major hospitals • 25%
81%-90% • 25%
More than 90% • 25%
Less than 70% • 25%
70%-80% • 25%
51% to 75% • 25%
More than 75% • 25%
25% to 50% • 25%
Less than 25% • 25%
Below 70% efficacy • 25%
70-79% efficacy • 25%
80-90% efficacy • 25%
Above 90% efficacy • 25%
51-75% reduction • 25%
0-25% reduction • 25%
26-50% reduction • 25%
76-100% reduction • 25%
Above 40% • 25%
Below 20% • 25%
20% to 30% • 25%
30% to 40% • 25%
Moderate Improvement • 25%
Worse Outcomes • 25%
No Change • 25%
Significant Improvement • 25%
50,001 to 100,000 • 25%
Less than 10,000 • 25%
10,000 to 50,000 • 25%
More than 100,000 • 25%